Biotech

All Articles

Angelini pens $360M biobucks treaty for ph. 1 mind problem medication

.Italy's Angelini Pharma has actually authorized a $360 thousand biobucks deal centered on a phase 1...

Sage gives up half of R&ampD group and shakes up C-suite once again

.Sage Rehabs' most up-to-date attempt to reduce its own pipe and workforce will certainly see a 3rd ...

With stage 1 data, Feeling possesses an eye on early-stage bladder cancer cells

.Along with its lead prospect in a stage 3 trial for an uncommon eye cancer, Aura Biosciences is wan...

Less than a year in, BenevolentAI CEO is actually out-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of significant management hirings, shootings ...

Roche MAGE-A4 test removed after calculated testimonial

.Roche has produced an additional MAGE-A4 plan vanish, taking out a stage 1 test of a T-cell bispeci...

FDA puts partial hold on BioNTech-OncoC4 period 3 test

.The FDA has implemented a partial hold on a phase 3 non-small mobile lung cancer practice run throu...

REGiMMUNE, Kiji merge to create Treg 'very firm,' program IPO

.Taiwan's REGiMMUNE as well as Europe-based Kiji Rehabs are actually merging to generate an internat...

With trial win, Merck aims to take on Sanofi, AZ in RSV

.Three months after disclosing that its own breathing syncytial infection (RSV) preventive antitoxin...

Noema ticks off phase 2a Tourette succeed for ex-Roche molecule

.Noema Pharma has acquired a stage 2a succeed for its Tourette syndrome drug candidate, disclosing a...

Terray sets up $120M series B to development AI-powered particles

.Terray Rehabs has raked in $120 thousand for a collection B fundraise as the AI-focused biotech goa...